Bengaluru-based deeptech innovator Nexstem recently closed a $3.5 million funding round, led by high-profile investors such as InfoEdge, Zupee, Smile Group, and Gruhas, co-founded by Nikhil Kamath and Abhijeet Pai. The investment signals confidence in Nexstem’s mission to advance non-invasive Brain-Computer Interface (BCI) technology.
Nexstem, founded by Siddhant Dangi and Deepansh in 2020, is pioneering the neurotech landscape with its flagship BCI product suite, Instinct. This advanced technology integrates a proprietary AI-powered compute module designed to analyze various biosignals, enhancing the understanding and interaction between human minds and external devices. Nexstem plans to use the funding to expand its product ecosystem, grow its intellectual property portfolio, and scale up operations to meet the increasing global demand for neurotechnology.
Brain-Computer Interface technology, once a concept reserved for science fiction, is now emerging as a transformative tool with applications in restoring motor functions, augmenting cognitive abilities, and creating new dimensions for human-machine interaction. Nexstem’s platform aims to make these innovations more accessible by lowering costs and simplifying access to EEG and other neurotechnology solutions. The funds will further support Nexstem’s expansion into American and European markets, along with efforts to obtain regional certifications and compliance for a broader reach.
“With this funding, we are excited to advance the deployment of our BCI ecosystem, which we believe will redefine how technology can address real-world challenges across diverse sectors,” said Siddhant Dangi, Nexstem’s CEO.
Dangi added, “Our focus is on harnessing complex biosignal data from the human body, which will help us create better products, highly customized services, and a deeper understanding of human cognition. By addressing these challenges, we are opening doors to applications once imagined in sci-fi, such as longevity and telepathy. Our approach as an early platform player enables us to help others realize impactful use cases in neurotechnology, carefully balancing innovation with practical applications.”
The company’s roadmap for the coming years includes the release of new offerings, such as Nexstem Coin, EXG modules, and tACS technology, expanding Nexstem’s product suite. Nexstem’s work is also attracting interest in the defense and consumer sectors, where they plan to build a robust distribution network.
Vibhore Sharma from Tech Investments, InfoEdge, expressed excitement about the future of BCI, stating, “We believe that BCI would emerge as an extremely transformative technology in the next decade or so, and we are very excited to back the Nexstem team in their endeavor in this space. In an industry characterized by lengthy development cycles and substantial investment, Nexstem’s progress has been fast, frugal, and exceptional.”
Abhijeet Pai, Co-Founder of Gruhas, shared similar enthusiasm, remarking, “At Gruhas, we are committed to backing innovative technologies that redefine the way we interact with and understand the world. Nexstem’s advancements in BCI are at the frontier of what’s possible in neurotechnology, with the potential to unlock new dimensions of human capability. We are thrilled to support Nexstem’s journey as it expands its ecosystem and makes cutting-edge neurotech accessible to diverse industries.”
